When was FRONTIER SMALL CAP GROWTH FUND, L.P.'s most recent SEC filing?

FRONTIER SMALL CAP GROWTH FUND, L.P.'s most recent Form D filing was on 2026-09-17.

How many investors does FRONTIER SMALL CAP GROWTH FUND, L.P. have?

The most recent Form D filing lists 49 investor(s).

FRONTIER SMALL CAP GROWTH FUND, L.P.

CIK: 0001232646·Pooled Investment Fund·BOSTON, MA·Limited Partnership

Reported Sold

N/A

Total Filings

Identified Offerings

Last Filed

Sep 17, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately. 16 unlinked amendments excluded.

Offering filing timeline

Sep 17, 2026Form D/A — Amendment

Reported sold: $180,233,667 · Target: Indefinite

Rule 506(b)·49 investors·Section 3(c), Section 3(c)(1)

Changed: Offering target, Sales commissions, Finders fees, Non-accredited investors

Dec 3, 2025Form D/A — Amendment

Reported sold: $180,233,667 · Target: N/A

No verified predecessor available.

Rule 506(b)·49 investors·Section 3(c), Section 3(c)(1)

Dec 3, 2024Form D/A — Amendment

Reported sold: $179,943,667 · Target: Indefinite

Rule 506(b)·49 investors·Section 3(c), Section 3(c)(1)

Dec 8, 2023Form D/A — Amendment

Reported sold: $179,943,667 · Target: Indefinite

Rule 506(b)·49 investors·Section 3(c), Section 3(c)(1)

Dec 9, 2022Form D/A — Amendment

Reported sold: $179,943,667 · Target: Indefinite

Rule 506(b)·49 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 10, 2021Form D/A — Amendment

Reported sold: $147,593,667 · Target: Indefinite

Rule 506(b)·48 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 10, 2020Form D/A — Amendment

Reported sold: $145,393,873 · Target: Indefinite

No verified predecessor available.

Rule 506(b)·46 investors·Section 3(c), Section 3(c)(1)

Dec 18, 2018Form D/A — Amendment

Reported sold: $143,342,528 · Target: Indefinite

Rule 506(b)·46 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 21, 2017Form D/A — Amendment

Reported sold: $137,549,416 · Target: Indefinite

Rule 506(b)·45 investors·Section 3(c), Section 3(c)(1)

Dec 21, 2016Form D/A — Amendment

Reported sold: $137,549,416 · Target: Indefinite

Rule 506(b)·45 investors·Section 3(c), Section 3(c)(1)

Dec 23, 2015Form D/A — Amendment

Reported sold: $137,549,416 · Target: Indefinite

Rule 506(b)·45 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 24, 2014Form D/A — Amendment

Reported sold: $170,092,182 · Target: Indefinite

Rule 506(b)·50 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Dec 31, 2013Form D/A — Amendment

Reported sold: $211,001,076 · Target: Indefinite

Rule 506(b)·55 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors, Exemptions

Jan 3, 2013Form D/A — Amendment

Reported sold: $222,147,063 · Target: Indefinite

Rule 506·59 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Jan 4, 2012Form D/A — Amendment

Reported sold: $205,686,036 · Target: Indefinite

Rule 506·59 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold, Reported investors

Jan 4, 2011Form D/A — Amendment

Reported sold: $188,311,036 · Target: Indefinite

No verified predecessor available.

Rule 506·55 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

N/A

Amendment Rate

100%

Latest reported sold across 0 identified offerings

N/A

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

16 unlinked amendments excluded.

Key People

MICHAEL A. CAVARRETTA

Related Person

Appears on 9 filings

RICHARD H. BINDER

Related Person

Appears on 8 filings

STEPHEN M. KNIGHTLY

Related Person

Appears on 8 filings

WILLIAM J. BALLOU

Related Person

Appears on 7 filings

ROBERT E. PHAY, JR.

Executive Officer

Appears on 6 filings

SARAH J. JANKOWSKI

Executive Officer

Appears on 6 filings

WILLIAM A. TEICHNER

Related Person

Appears on 5 filings

JULIANNE HULL

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 17, 2026	Amendment	Indefinite	$180,233,667	49
Dec 3, 2025	Amendment	N/A	$180,233,667	49
Dec 3, 2024	Amendment	Indefinite	$179,943,667	49
Dec 8, 2023	Amendment	Indefinite	$179,943,667	49
Dec 9, 2022	Amendment	Indefinite	$179,943,667	49
Dec 10, 2021	Amendment	Indefinite	$147,593,667	48
Dec 10, 2020	Amendment	Indefinite	$145,393,873	46
Dec 18, 2018	Amendment	Indefinite	$143,342,528	46
Dec 21, 2017	Amendment	Indefinite	$137,549,416	45
Dec 21, 2016	Amendment	Indefinite	$137,549,416	45
Dec 23, 2015	Amendment	Indefinite	$137,549,416	45
Dec 24, 2014	Amendment	Indefinite	$170,092,182	50
Dec 31, 2013	Amendment	Indefinite	$211,001,076	55
Jan 3, 2013	Amendment	Indefinite	$222,147,063	59
Jan 4, 2012	Amendment	Indefinite	$205,686,036	59
Jan 4, 2011	Amendment	Indefinite	$188,311,036	55

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

AVSF - Integrated Biosciences 2026, LLC

Pooled Investment Fund

Offering target: Indefinite

Filed Nov 5, 2026